Zobrazeno 1 - 10
of 156
pro vyhledávání: '"Efthymios N Deliargyris"'
Autor:
Marijana Matejic-Spasic, Sandra Lindstedt, Guillaume Lebreton, Omer Dzemali, Piotr Suwalski, Thierry Folliguet, Stephan Geidel, Robert J. M. Klautz, Christophe Baufreton, Ugolino Livi, Serdar Gunaydin, Efthymios N. Deliargyris, Daniel Wendt, Matthias Thielmann
Publikováno v:
BMC Cardiovascular Disorders, Vol 24, Iss 1, Pp 1-20 (2024)
Abstract Background Extracorporeal blood purification has been widely used in intensive care medicine, nephrology, toxicology, and other fields. During the last decade, with the emergence of new adsorptive blood purification devices, hemoadsorption h
Externí odkaz:
https://doaj.org/article/91a8b3c9676b45f89e89cc467bed487c
Autor:
Kambiz Hassan, MD, Stephan Geidel, MD, PhD, Vipin Zamvar, MD, Kenichi Tanaka, MD, Zelka Knezevic-Woods, MD, Daniel Wendt, MD, PhD, MHBA, Efthymios N. Deliargyris, MD, Robert F. Storey, MD, DM, Michael Schmoeckel, MD, PhD
Publikováno v:
JTCVS Open, Vol 15, Iss , Pp 190-196 (2023)
Objectives: Patients on ticagrelor undergoing urgent cardiac surgery are at high risk for perioperative bleeding complications. We sought to determine whether intraoperative hemoadsorption could remove ticagrelor and lower circulating drug concentrat
Externí odkaz:
https://doaj.org/article/7344eb2749eb4021b2accb63956c54ba
Autor:
J. W. Awori Hayanga, Tae Song, Lucian Durham, Lawrence Garrison, Deane Smith, Zsolt Molnar, Joerg Scheier, Efthymios N. Deliargyris, Nader Moazami
Publikováno v:
Critical Care, Vol 27, Iss 1, Pp 1-9 (2023)
Abstract Objectives The CytoSorb therapy in COVID-19 (CTC) registry evaluated the clinical performance and treatment parameters of extracorporeal hemoadsorption integrated with veno-venous extracorporeal membrane oxygenation (VV ECMO) in critically i
Externí odkaz:
https://doaj.org/article/14012d99a45e41fe8f70ac2d64f69ead
Autor:
Joerg Scheier, MD, Peter J. Nelson, MD, FASN, Antoine Schneider, MD, PhD, Sébastien Colombier, MD, Detlef Kindgen-Milles, MD, PhD, Efthymios N. Deliargyris, MD, FACC, FESC, FSCAI, Thomas D. Nolin, PharmD, PhD
Publikováno v:
Critical Care Explorations, Vol 4, Iss 5, p e0688 (2022)
OBJECTIVE:. The CytoSorb hemoadsorption device (CytoSorbents Inc, Monmouth Junction, NJ) is increasingly used in many critical disease states. The potential impact on the pharmacokinetic (PK) of concomitantly administered drugs must be considered in
Externí odkaz:
https://doaj.org/article/125b516ba4524b6db74fc6c9a0163a1f
Autor:
J. Antonio Gutierrez, Robert A. Harrington, Gregg W. Stone, Ph. Gabriel Steg, C. Michael Gibson, Christian W. Hamm, Matthew J. Price, Renato D. Lopes, Sergio Leonardi, Jayne Prats, Efthymios N. Deliargyris, Kenneth W. Mahaffey, Harvey D. White, Deepak L. Bhatt
Publikováno v:
American Heart Journal Plus, Vol 9, Iss , Pp 100043- (2021)
Background: Peripheral artery disease (PAD) is associated with an increased risk of ischemic events following percutaneous coronary intervention (PCI). More aggressive antiplatelet therapy may mitigate this risk. The present study evaluates the effic
Externí odkaz:
https://doaj.org/article/40d09d1a24894368ac22ac4efaa3424d
Publikováno v:
Critical Care Research and Practice, Vol 2021 (2021)
The COVID-19 pandemic has led to the biggest global health crisis of our lifetime. There is accumulating evidence that a substantial number of critically ill COVID-19 patients exhibit a dysregulated host response manifesting as cytokine storm or cyto
Externí odkaz:
https://doaj.org/article/0f3361637f91429ca01c70168a9d8ed5
Autor:
Davide Cao, Nicolas Amabile, Mauro Chiarito, Victoria T Lee, Dominick J Angiolillo, Davide Capodanno, Deepak L Bhatt, Michael J Mack, Robert F Storey, Michael Schmoeckel, C Michael Gibson, Efthymios N Deliargyris, Roxana Mehran
Publikováno v:
European Heart Journal. 44:1780-1794
Remarkable progress has been made in the pharmacological management of patients with cardiovascular disease, including the frequent use of antithrombotic agents. Nonetheless, bleeding complications remain frequent and potentially life-threatening. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ca08403f9de7b2faf8f83e24a41e2ae
https://doi.org/10.1093/eurheartj/ehad119
https://doi.org/10.1093/eurheartj/ehad119
Autor:
Yiorgos A. Bobetsis, Ioannis Kotsikoris, Christos D. Liapis, Nikolaos Liasis, John Kakisis, Georgia Kourlaba, Paraskevi Lazari, Constantine N. Antonopoulos, Efthymios N. Deliargyris, Phoebus N. Madianos
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 30, Iss , Pp 100601- (2020)
Background: Periodontal disease (PD) is a chronic inflammatory oral condition with potentially important systemic sequelae. We sought to determine whether the presence of PD in patients with severe carotid disease was associated with morphological fe
Externí odkaz:
https://doaj.org/article/1d7d10bce7174172a904537d65732fd0
Autor:
Francesco Franchi, David J. Schneider, Jayne Prats, Weihong Fan, Fabiana Rollini, Latonya Been, Heidi S. Taatjes-Sommer, Deepak L. Bhatt, Efthymios N. Deliargyris, Dominick J. Angiolillo
Publikováno v:
Journal of Thrombosis and Thrombolysis. 54:373-381
Low dose enteric-coated aspirin (EC-ASA) is routinely used for secondary cardiovascular event prevention. However, absorption of EC tablets is poor, which can result in subtherapeutic antiplatelet effects. Phospholipid-aspirin liquid filled capsules
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::533afdede1ad510427e7415a281cf731
https://doi.org/10.1007/s11239-022-02687-5
https://doi.org/10.1007/s11239-022-02687-5
Autor:
Benjamin G. Cohen, Francine Chingcuanco, Jingwei Zhang, Natalie M. Reid, Victoria Lee, Jonathan Hong, Efthymios N. Deliargyris, William V. Padula
Publikováno v:
American Journal of Cardiovascular Drugs.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::06b0fa5cf1b671cb3875b16ff6386dc8
https://doi.org/10.1007/s40256-023-00587-4
https://doi.org/10.1007/s40256-023-00587-4